Lancet Oncology

The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now the world-leading clinical oncology periodical publishing high-quality, peer-reviewed research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academic centres). Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. Much of the journal’s articles are published Online First for enhanced timeliness prior to print publication. Uniquely, all original research is peer-reviewed via a fast-track service, and successful papers are published within 8 weeks of submission. The journal also regularly features podcasts, video, infographics, and curated web content.

Publisher
Elsevier
Website
http://www.thelancet.com/journals/lanonc/issue/current
Impact factor
33.9 (2016)

Some content from Wikipedia, licensed under CC BY-SA

Medications

First report card on biosimilars in oncology

Researchers have developed the first report card on biosimilars for three blockbuster cancer drugs marketed by Genentech/Roche: Rituxan, Avastin and Herceptin. In a Policy Review in The Lancet Oncology, Y. Tony Yang, a professor ...

Oncology & Cancer

Climate change will give rise to more cancers

Climate change will bring an acute toll worldwide, with rising temperatures, wildfires and poor air quality, accompanied by higher rates of cancer, especially lung, skin and gastrointestinal cancers, according to a new report ...

Oncology & Cancer

Vital rethinking in cancer early detection needed to save lives

Earlier detection of cancer offers arguably the single biggest opportunity to save lives from the disease, but there are many challenges of seeing this a reality for patients in the NHS, according to Cancer Research UK's ...

Oncology & Cancer

Breast screening women in their forties saves lives

Breast screening women aged 40-49 reduces breast cancer mortality, with minimal increased overdiagnosis, according to a study led by Queen Mary University of London that looked at data from 160,000 women.

page 1 from 27